Coverage
-
November 01, 2012
A Pennsylvania federal judge struck a blow to GlaxoSmithKline PLC on Thursday, ruling that plaintiffs in a class action accusing it of illegally blocking development of a generic Flonase could tap former U.S. Food and Drug Administration chief David Kessler as an expert witness.
1 other articles on this case.
View all »